Trial reportNature2024
Last-mile delivery increases vaccine uptake in Sierra Leone.
Trial report in Nature, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Health, economic, and equity impact of a COVID-19 mobile vaccine clinic program in US: a cost-effectiveness analysis.Lancet regional health. Americas · 2026Article
- Improving human papillomavirus vaccine uptake in low- and middle-income countries: a narrative review of implementation and education strategies.BMC global and public health · 2026Review
- From Product Availability to Population Protection: Vaccine Deployment Readiness in Sierra Leone.Annals of global health · 2026Article
- Effectiveness of mobile vaccine clinics on COVID-19 vaccination uptake in the USA: an observational study.BMJ public health · 2026Article
- Last mile at the center of immunization delivery.Frontiers in epidemiology · 2026Article
- Article
- Gender and Socio-Economic Inequities in Social Listening: Evidence from Two Quantitative Case Studies in India.Asian bioethics review · 2025Article
- Article
- Trends and inequalities in full immunisation coverage among one-year-olds in Sierra Leone, 2008-2019.BMC pediatrics · 2025Article
- The cost of delivering COVID-19 vaccines in Mozambique: a bottom-up costing study.BMC health services research · 2025Article
- ICED OUT: integrated cold-chain eliminating disease outreach. Piloting a motorcycle-enabled laboratory transport system combatting visceral leishmaniasis in rural Kenya.Frontiers in public health · 2025Article
- A qualitative analysis exploring barriers and enablers to distribution, delivery, and access to COVID-19 vaccines in Botswana.Frontiers in health services · 2025Article
- Article
- Vaccines save lives: how can uptake be increased?Nature · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Less than 30% of people in Africa received a dose of the COVID-19 vaccine even 18 months after vaccine development
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.